Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
Currently predicting for Mon, 13 May 2024

Trading levels for ORMP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.49 4.04 %
R2 2.46 2.52 %
R1 2.43 1.58 %
Current price: 2.40
Support S1 2.36 -1.45 %
S2 2.34 -2.38 %
S3 2.30 -3.90 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.87 19.83 %
R2 2.86 19.42 %
R1 2.61 8.98 %
Current price 2.40
Support S1 2.34 -2.30%
S2 2.33 -2.71%
S3 2.20 -8.14%

ORMP Predictions History

3 years ago
JS predicted that ORMP for 2021-05-03 is going $10.52 (-4.88%)

3 years ago
SebastianRyszkiewicz predicted that ORMP for 2021-05-03 is going

Rank:

3 years ago
dylannedwardbrennan.232622 predicted that ORMP for 2021-05-03 is going $10.90 (2.25%)

Rank:

3 years ago
nocrashrc predicted that ORMP for 2021-05-03 is going

Rank:

3 years ago
JS predicted that ORMP for 2020-06-15 is going $3.83 (-2.30%)

3 years ago
2poJeff predicted that ORMP for 2020-06-15 is going $4.12 (4.57%)

4 years ago
Michael Gregory predicted that ORMP for 2020-03-02 is going

Rank:

6 years ago
Iightstryk predicted that ORMP for 2017-09-12 is going $9.40 (5.03%)

Rank:

6 years ago
JS predicted that ORMP for 2017-09-08 is going $9.32 (3.44%)

7 years ago
JS predicted that ORMP for 2016-08-10 is going $7.83 (-1.76%)

Click to get the best stock tips daily for free!

About Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals. Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes. It is also developing ORMD-0901, an oral glucagon-like peptid... ORMP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT